France allows stem cell work

New bioethics law permits ES cell research, but not cloning

Written byCatherine Brahic
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The French Parliament last Friday (July 9) adopted a new bioethics law that allows embryonic stem cell research, and for at least one research group, the decision has made the difference between conducting their work in France or the United States.

The new law states that human reproductive cloning is a "crime against the human species," and although therapeutic cloning will remain illegal in France, research on embryonic stem cells will be allowed within strict parameters.

"For the first time, thanks to the law on bioethics, reproductive cloning is very clearly made a crime against the human species, and therapeutic cloning an offense," said Philippe Douste-Blazy, minister of health. "Protecting human embryos is an explicit goal of the civil code," he added. Reproductive cloning experiments will be punishable by up to 20 years in prison.

However, in recognition of their medical potential, Douste-Blazy and François d'Aubert, minister of research, will ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies